Regeneron Pharmaceuticals Inc

Common Name

Regeneron Pharmaceuticals

Country

United States

Sector

Healthcare

Industry

Biotechnology

Employees

15,222

Ticker

REGN

Exchange

NASDAQ/NGS

Website

www.regeneron.com

Description

Regeneron Pharmaceuticals, Inc. is a biotechnology company focused on the discovery, development, manufacturing, and commercialization of innovative medicines that address serious medical conditions. ... Show more

Income Statement Balance Sheet Group Entities

Regeneron Pharmaceuticals's Group Entities Data Preview

The Group Entity dataset is currently being compiled; join the waitlist to secure early access!

As of the end of fiscal year 2024, Tracenable has captured detailed data on Regeneron Pharmaceuticals's corporate ownership structure, providing a comprehensive view of its downstream entities and the role within the broader group hierarchy.^a

The dataset includes information on 32 affiliated entities, encompassing subsidiaries, joint ventures, associates, and other related companies in which Regeneron Pharmaceuticals holds an equity interest or exercises control as the ultimate parent.^a

Tracenable's data also records effective ownership percentages that Regeneron Pharmaceuticals holds across these entities, providing transparency into its corporate control, ownership hierarchy, and group governance practices.^a

Entity Name	Country	Type	Ownership	LEI	PermID
Checkmate Pharmaceuticals, Inc.^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	USA	Subsidiary	Not Specified	0000000	0000000
Decibel Therapeutics, Inc.^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	USA	Subsidiary	Not Specified	0000000	0000000
Eastside Campus Holdings LLC^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	USA	Subsidiary	Not Specified	0000000	0000000
Loop Road Holdings LLC^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	USA	Subsidiary	Not Specified	0000000	0000000
Old Saw Mill Holdings LLC^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	USA	Subsidiary	Not Specified	0000000	0000000
OSMR Holdings^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	BMU	Subsidiary	Not Specified	0000000	0000000
Oxular Acquisitions Limited^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	GBR	Subsidiary	Not Specified	0000000	0000000
Oxular Inc.^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	USA	Subsidiary	Not Specified	0000000	0000000
Oxular Limited^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	GBR	Subsidiary	Not Specified	0000000	0000000
Regeneron Assurance, Inc.^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	USA	Subsidiary	Not Specified	0000000	0000000
Regeneron Atlantic Holdings^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	BMU	Subsidiary	Not Specified	0000000	0000000
Regeneron Austria GmbH^a Trace this value back to its sources Viewing source references is available to registered users. Create a Tracenable account to view up to 5 source references at no cost. Sign Up	AUT	Subsidiary	Not Specified	0000000	0000000
0000000	0000000	0000000	0000000	0000000	0000000
0000000	0000000	0000000	0000000	0000000	0000000
Showing 12 out of 32 entities. Get complete coverage in the full dataset.

Limited Data Preview

You are viewing a limited preview of Regeneron Pharmaceuticals’s Group Entities dataset. The full dataset, available for download, includes the complete group structure, covering subsidiaries, associates, joint ventures, and other related entities, along with direct and indirect ownership relationships where available.

Unrestricted Access to Data and Sources

pro

Remove manual data sourcing from your workflow. Upgrade to Tracenable Pro for unrestricted access to datasets and disclosures across 8,500+ companies with over 10 years of historical coverage.

Download complete datasets (CSV/XLS)

Access underlying corporate disclosures (PDF)

Trace values back to original sources

Upgrade to Tracenable Pro

Formats Included

Excel

CSV

All data fully traceable to original sources

Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Regeneron Pharmaceuticals’s Group Entities Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Regeneron Pharmaceuticals’s data sources below and access millions more through our Disclosure Search.

a. Regeneron Pharmaceuticals's Financial & Extra-Financial Disclosure 2024

Insights into Regeneron Pharmaceuticals's Group Entities Location

Tracenable's dataset provides geographic insights into Regeneron Pharmaceuticals's group entities, revealing where its subsidiaries, joint ventures, associates, and affiliates are located worldwide.^a

In total, the Regeneron Pharmaceuticals group consists of 31 entities distributed across 15 countries, reflecting the company's global footprint and jurisdictional presence.^a

This visualization highlights the geographical distribution of Regeneron Pharmaceuticals's corporate structure, helping assess its international exposure, operational reach, and cross-border governance landscape.^a

How geographically diverse is Regeneron Pharmaceuticals's corporate structure?

In 2024, Tracenable identified that the Regeneron Pharmaceuticals group consisted of 31 entities operating across 15 countries.^a

This indicates a moderate geographic diversification, reflecting Regeneron Pharmaceuticals's expansion strategy, global footprint, and cross-border exposure.^a

What does the geographic footprint of Regeneron Pharmaceuticals reveal about its business operations?

Regeneron Pharmaceuticals's subsidiaries and affiliates are primarily concentrated in North America and Europe, which host 93.75% of its total entities.^a

This regional distribution suggests that Regeneron Pharmaceuticals's operational and financial activities are centered in these markets, either due to core business operations, supply chain proximity, or favorable regulatory environments.

How transparent is Regeneron Pharmaceuticals about its group entities and ownership structure?

Regeneron Pharmaceuticals shows a moderate to high level of transparency regarding its ownership structure.

The disclosure includes information on subsidiaries, joint ventures, and associates, allowing partial visibility into the company's downstream relationships and areas of shared control.^a

While not a full edge-level disclosure, the data still provides meaningful insight into Regeneron Pharmaceuticals's governance framework and group composition, positioning it among more transparent reporters in its industry.

Does Regeneron Pharmaceuticals maintain entities in low-tax or offshore jurisdictions?

Yes. Tracenable's data shows that 2 entities (6.25%) are registered in jurisdictions commonly classified as low-tax or offshore financial centers, such as Bermuda.^a

This may indicate tax optimization strategies or the use of special-purpose vehicles (SPVs) within Regeneron Pharmaceuticals's ownership structure.

Explore Peer Companies

Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals's Group Entities Data Preview

Verified Sources Behind Regeneron Pharmaceuticals’s Group Entities Data

Insights into Regeneron Pharmaceuticals's Group Entities Location

How geographically diverse is Regeneron Pharmaceuticals's corporate structure?

What does the geographic footprint of Regeneron Pharmaceuticals reveal about its business operations?

How transparent is Regeneron Pharmaceuticals about its group entities and ownership structure?

Does Regeneron Pharmaceuticals maintain entities in low-tax or offshore jurisdictions?

Explore Peer Companies

Alnylam Pharmaceuticals Inc

Biohaven Ltd

Insmed Inc

Gilead Sciences Inc

Edwards Lifesciences Corp

Amgen Inc